St. Louis Trust Co Buys 1,233 Shares of Axon Enterprise, Inc $AXON

St. Louis Trust Co boosted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 80.9% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,757 shares of the biotechnology company’s stock after buying an additional 1,233 shares during the quarter. St. Louis Trust Co’s holdings in Axon Enterprise were worth $1,171,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of the company. Creative Financial Designs Inc. ADV purchased a new stake in shares of Axon Enterprise in the fourth quarter valued at $28,000. Sound Income Strategies LLC boosted its stake in shares of Axon Enterprise by 550.0% during the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after purchasing an additional 44 shares during the period. Camelot Portfolios LLC purchased a new position in shares of Axon Enterprise during the 4th quarter worth about $30,000. AlphaCentric Advisors LLC bought a new position in Axon Enterprise during the 4th quarter valued at about $34,000. Finally, Lodestone Wealth Management LLC bought a new position in Axon Enterprise during the 4th quarter valued at about $35,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Up 2.1%

NASDAQ AXON opened at $502.34 on Friday. The stock has a market cap of $40.49 billion, a PE ratio of 201.74, a PEG ratio of 10.04 and a beta of 1.38. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $885.91. The company’s 50-day moving average price is $483.26 and its 200-day moving average price is $479.59. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.49.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The company had revenue of $807.35 million during the quarter, compared to analyst estimates of $778.90 million. During the same quarter last year, the business posted $1.47 EPS. The firm’s revenue for the quarter was up 33.7% on a year-over-year basis. Equities research analysts forecast that Axon Enterprise, Inc will post 1.63 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on AXON shares. Morgan Stanley set a $600.00 price objective on shares of Axon Enterprise in a research report on Thursday, May 7th. Needham & Company LLC boosted their target price on Axon Enterprise from $600.00 to $750.00 and gave the company a “buy” rating in a research report on Monday, July 6th. Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 10th. The Goldman Sachs Group set a $535.00 price target on Axon Enterprise in a report on Thursday, May 7th. Finally, JPMorgan Chase & Co. increased their price target on Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Fifteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $725.25.

Insiders Place Their Bets

In other news, President Joshua Isner sold 13,000 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the transaction, the president directly owned 169,125 shares of the company’s stock, valued at approximately $82,609,106.25. This trade represents a 7.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CRO Cameron Brooks sold 1,242 shares of Axon Enterprise stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total transaction of $621,000.00. Following the sale, the executive directly owned 49,710 shares of the company’s stock, valued at $24,855,000. This represents a 2.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 58,989 shares of company stock worth $30,527,983. 4.20% of the stock is owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.